Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v2.4.0.6
Consolidated Balance Sheets (USD $)
Mar. 31, 2012
Dec. 31, 2011
ASSETS    
Cash and cash equivalents $ 120,000 $ 92,000
Inventories 12,000 12,000
Prepaid expenses 12,000   
Total Current Assets 144,000 104,000
Patents, net 22,000 25,000
Total Other Assets 22,000 25,000
TOTAL ASSETS 166,000 129,000
LIABILITIES AND STOCKHOLDERS' DEFICIT    
Accounts payable 815,000 806,000
Accrued interest 1,442,000 1,598,000
Accrued expenses 669,000 607,000
Line of credit 25,000 25,000
Warrant liability 303,000 158,000
Demand notes payable, net of discount of $25,000 and $54,000 238,000 266,000
Convertible debentures, net of discount of $0 and $0, current portion 995,000 775,000
Convertible debentures 942,000 995,000
Total Current Liabilities 5,429,000 5,230,000
Stockholders' Deficit:    
Convertible preferred stock - $0.001 par value; 15,000,000 shares authorized: Series C - 96,230 and 96,230 shares issued and outstanding at March 31, 2012 and December 31, 2011, respectively 1,000 1,000
Series H - 25,000 and 25,000 shares issued and outstanding at March 31, 2012 and December 31, 2011, respectively      
Series I - 1,666,667 and 1,666,667 shares issued and outstanding at March 31, 2012 and December 31, 2011, respectively 2,000 2,000
Common stock - $0.001 par value; 600,000,000 shares authorized; 300,299,838 and 269,299,838 shares issued and outstanding at March 31, 2012 and December 31, 2011, respectively 300,000 269,000
Additional paid-in capital 78,844,000 78,422,000
Accumulated deficit (84,410,000) (83,795,000)
Total Stockholders' Deficit (5,263,000) (5,101,000)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT $ 166,000 $ 129,000